Autolus Therapeutics plc American Depositary Share (NASDAQ: AUTL) last traded at $2.41, down 2.03% on the session. The quote above updates while this page is open; the figures below are drawn from Autolus Therapeutics plc American Depositary Share’s own filings and are restated only when a new one is published.
Autolus Therapeutics plc American Depositary Share trades on NASDAQ under the ticker AUTL. Its market capitalisation is $641.45 million.
Valuation measures for Autolus Therapeutics plc American Depositary Share, derived from the latest quote and its most recent SEC filing.
| Market cap | $641.45M |
|---|---|
| Enterprise value | $888.42M |
| Price / sales | 5.46 |
| Price / book | 8.57 |
| Beta | 1.97 |
Trailing-twelve-month figures tagged in Autolus Therapeutics plc American Depositary Share's XBRL filings with the SEC.
| Revenue (TTM) | $117.39M |
|---|---|
| Net income (TTM) | -$280.16M |
| EPS (TTM) | -$1.06 |
| Operating margin | -210.78% |
| Return on equity | -374.35% |
| Cash | $171.41M |
Range and volume for AUTL over the past 52 weeks.
| 52-week high | $2.58 |
|---|---|
| 52-week low | $1.18 |
| Volume | 2.32M |
| Average volume | 1.92M |
| Previous close | $2.46 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.